Search clinical trials for: Tolterodine+%26+Pregabalin

Total 670 results

Nestlé

Completed

Stool Composition and Stool Characteristics in Healthy Term Infants Fed Human Milk or Infant Formulas

Stool Composition

Philippines
Pfizer

Completed

Investigation of Tolterodine, Pregabalin and a Tolterodine - Pregabalin Combination for the Treatment of Overactive Bladder

Overactive Bladder

Czech Republic, Slovakia, United Kingdom, Sweden, Norway, Lithuania
Albert Einstein Healthcare Network

Recruiting

Cesarean Section Skin Prep - Does Skin Preparation Pattern Affect Skin Bacterial Burden

Cesarean Section Complications | Wound Infection

United States
Wageningen University

Completed

The Fasting Study - Unraveling the Mechanistic Effects of Prolonged Fasting in Humans.

Fasting | Clinical Trial | Lipid Metabolism | Adipose Tissue

Netherlands
Chania General Hospital "St. George"
AHEPA University Hospital of Thessaloniki Thessaloniki, Greece

Completed

Anxiety, Depression and Eating Attitudes of Diabetes Mellitus Patients During COVID-19 Lockdown in Greece

Diabetes Mellitus | SARS-CoV-2

Greece
Merck Sharp & Dohme LLC

Completed

A Study to Test the Effects of Tolterodine Tartrate in Patients With Overactive Bladder (0000-107)

Overactive Bladder
Universiti Putra Malaysia

Recruiting

Effect of Chen Taichi on College Students' Physical and Psychological Health.

Physical Inactivity | Mental Health Issue

China
Assistance Publique - Hôpitaux de Paris

Completed

Prenatal Endoscopic Repair of Fetal Spina Bifida (ENDOSPIN)

Myelomeningocele

France
Peking University People's Hospital

Unknown

the Indications and Clinical Efficacy of Pelvic Organ Prolapse Surgery

Pelvic Organ Prolapse

China
National University of Malaysia

Unknown

Minimizing Pain Experience In Trigger Finger Steroid Injection.

Trigger Finger

Malaysia
KYU-SUNG LEE
Pfizer

Completed

Exploring Predictors of Symptoms Relapse After Discontinuation of Treatment in Overactive Bladder (OAB) Patients

Overactive Bladder

Korea, Republic of
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Tolterodine Drug Use Investigation.(Post Marketing Commitment Plan) (POTTOR)

Overactive Bladder
University of Gaziantep

Unknown

The Relationship of Orthodontic Malocclusions With Temporomandibular Joint Disorders

Temporomandibular Joint Disorders

Turkey
Radboud University Medical Center

Recruiting

The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly (BLUEBERRY)

Hypertension | Frailty | Orthostatic Hypotension | Orthostatic Intolerance | Cerebral Hypoperfusion | Old Age; Dementia

Netherlands
Oculus Innovative Sciences, Inc.

Completed

Efficacy and Tolerability Study of Device, RD047-26 for the Treatment of Mild to Moderate Atopic Dermatitis in Adults

Pruritus | Atopic Dermatitis

United States
Chang Gung Memorial Hospital
Sanofi

Unknown

Fabry Disease in Cerebrovascular Disease

Fabry Disease

Taiwan
RenJi Hospital

Not yet recruiting

Clinical Study of HIFU for Localized Prostate Cancer (HIFU)

Localized Prostate Cancer
Urovant Sciences GmbH

Completed

A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) (Empowur)

Overactive Bladder

United States, Latvia, Hungary, Canada, Lithuania, Poland
Ahon Pharmaceutical Co., Ltd.

Recruiting

Phase 1 Hepatic Insufficiency Trial of Methoxyethyl Etomidate Hydrochloride

Hepatic Insufficiency

China
Merck Sharp & Dohme LLC

Completed

A Study of the Efficacy and Safety of Vibegron (MK-4618) in Participants With Overactive Bladder (OAB) (MK-4618-008)

Urinary Bladder, Overactive
Mayo Clinic
Pfizer

Completed

Effects of Tolterodine, a Non-Specific Muscarinic Antagonist, on Gastrointestinal Transit in Healthy Subjects

Health

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A 5-treatment, Study in Healthy Volunteers to Assess The Safety, Tolerability, and Pharmacokinetics of Four Controlled Release (CR) Pregabalin Tablet Formulations and the Immediate Release (IR) Formulation Administered Fasted

Healthy

Belgium
Institut de Recherches Internationales Servier
ADIR, a Servier Group company

Terminated

Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children Aged From 2 to Less Than 7 Years Old With Autism Spectrum Disorder.

Autism Spectrum Disorder (ASD)

Spain, United States, Hungary, Poland, Australia, United Kingdom, Brazil, Czechia, France, Italy, Portugal, Slovakia
Region Skane
Lund University

Recruiting

Biomarkers for Ventilator-associated Pneumonia (VAPmarkers)

Pneumonia, Ventilator-Associated

Sweden
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study to Evaluate the Efficacy of Tolterodine on Specific Symptoms in Adult Patients With Overactive Bladder.

Urinary Bladder, Overactive

United States
Nestlé

Completed

Acceptability and GI Tolerance of an Alpha-lactalbumin-enriched Formula

Infant Formula Intolerance

Philippines
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Pharmacokinetics and Relative Bioavailability Study

Urinary Bladder, Overactive

Singapore
Ono Pharmaceutical Co. Ltd

Completed

Study of ONO-8539 in Patients With Overactive Bladder

Overactive Bladder

Poland, Ukraine, Romania, Russian Federation, Czech Republic, Hungary, Netherlands, Sweden, Germany
Far Eastern Memorial Hospital
National Science Council, Taiwan

Completed

Bladder Wall Blood Perfusion Pattern and Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms, and the Association of That Perfusion Pattern and Therapeutic Efficacy of Antimuscarincs for Female Overactive Bladder Syndrome.

Lower Urinary Tract Symptoms

Taiwan
Inje University

Completed

STUDY The Effect of HNF-4A G60D Variant on the In VIVO CYP2D6 Activity By Tolterodine Pharmacokinetic Study (HNF4a)

Healthy Subjects | Genotype Guided(HNF4a)
Mclean Hospital

Withdrawn

Magnetic Resonance Spectroscopy Studies of Acute Hypoxic and Hyperoxic Breathing in Healthy Volunteers

Healthy

United States
Uroplasty, Inc

Completed

Overactive Bladder Innovative Therapy Trial (OrBIT) (OrBIT)

Overactive Bladder

United States
Far Eastern Memorial Hospital

Recruiting

Comparisons of the Impact of Monotherapy With Mirabegron or Tolterodine Versus Combined Treatment With Mirabegron and Tolterodine on Autonomic Function and Bladder Blow Flow in Women With Overactive Bladder Syndrome: a Randomized Controlled Study

Female Patients With Overactive Bladder Syndrome

Taiwan
Brigham and Women's Hospital
Pfizer

Terminated

A Comparison of Tolterodine and Placebo Treatments on Nocturnal Frequency and Sleep Quality in Women After Menopause.

Urinary Incontinence

United States
HealthCore-NERI
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Behavior Enhances Drug Reduction of Incontinence (BE-DRI) (BE-DRI)

Urinary Incontinence (UI)

United States
Sanofi

Completed

MILADY: A Randomized, Placebo-controlled Safety and Efficacy Trial of SSR240600C in Treatment of Overactive Bladder or Urge Urinary Incontinence.

Overactive Bladder

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

A Study to Measure the Effect of Tolterodine Extended Release on the Thickness of the Bladder Wall in Patients With Overactive Bladder

Urinary Incontinence

United Kingdom
elbion AG

Terminated

ELB245 for 12 Weeks Versus 4mg Tolterodine in Patients With Incontinent Overactive Bladder (OAB)

Overactive Bladder | Urinary Incontinence

Sweden, Germany, Poland
Astellas Pharma Inc

Completed

Study to Assess the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder (SCORPIO)

Urinary Bladder, Overactive

Australia, Belgium, France, Spain, Sweden, Bulgaria, Romania, Italy, Greece, South Africa, Austria, Poland, United Kingdom, Hungary, Denmark, Netherlands, Switzerland, Ireland, Lithuania, Russian Federation, Germany, Latvia, Slovakia, Finlan... and more
Astellas Pharma Inc

Completed

Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder (TAURUS)

Urinary Bladder, Overactive

Canada, Poland, Belgium, Spain, Sweden, United States, Romania, Italy, France, Austria, United Kingdom, Germany, Hungary, Australia, Denmark, Netherlands, Switzerland, Lithuania, Russian Federation, Latvia, South Africa, Slovakia, F... and more
Sanofi

Completed

SSR240600C Treatment in Women With Overactive Bladder (BILADY)

Overactive Bladder

France, Germany, Netherlands, Portugal, Czech Republic, United States, Canada
Kissei Pharmaceutical Co., Ltd.

Completed

A Confirmatory Study of KUC-7483 in Patients With Overactive Bladder

Overactive Bladder

Japan
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women

Urinary Incontinence

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Evaluate Efficacy and Safety Of Tolterodine Extended Release Capsule Compared With Tolterodine Immediate Release Tablet

Urinary Incontinence

China
Pfizer's Upjohn has merged with Mylan to form Viatris...
Pfizer

Completed

Study to Determine The Effectiveness Of Detrusitol In Patients Diagnosed With OAB

Urinary Incontinence
Arog Pharmaceuticals, Inc.

Completed

Study of Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification

Recurrent/Refractory Glioblastoma

United States
Assiut University

Completed

Efficacy and Safety of Peri-operative Pregabalin After Radical Cystectomy

Postoperative Pain Following Radical Cystectomy
Pfizer's Upjohn has merged with Mylan to form Viatris...

Terminated

Web-based Methodology Trial to Evaluate the Efficacy and Safety of Tolterodine ER in Subjects With Overactive Bladder (REMOTE)

Overactive Bladder

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Evaluation of the Link Between Bladder Sensation and Changes in Skin Electrical Conductance and Heart Rate.

Overactive Bladder

Switzerland
National Taiwan University Hospital

Completed

Studies of Psychiatric Predisposing Factors, Treatment-related Cardiovascular Effects, and Prognostic Factors Associated With Antimuscarinic Drug (Tolterodine) for Female Overactive Bladder Syndrome

Antimuscarinic Drug

Taiwan

Search clinical trials for: Tolterodine+%26+Pregabalin

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Bulgaria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations